COVID-19

25 papers

• Molecular hydrogen as a treatment for ME/CFS: a mini-review of clinical evidence and mechanistic rationale.
  2026 ・ Front Med (Lausanne) ・ PMID 41930109
  hydrogen-rich water positive review
• [The combined use of inhaled nitric oxide and molecular hydrogen in patients with post-COVID-19 syndrome].
  2026 ・ Ter Arkh ・ PMID 41859790
  inhalation positive human randomized controlled trial
• [Efficiency and safety of the integrated use of medical gases thermal heliox, nitric oxide and molecular hydrogen in patients with exacerbation of chronic obstructive pulmonary disease complicated by hypoxemic, hypercapnic respiratory failure and secondary pulmonary arterial hypertension in the post-COVID period].
  2025 ・ Ter Arkh ・ PMID 40327618
  inhalation positive human randomized controlled trial
• Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial.
  2024 ・ J Clin Med ・ PMID 39124575
  hydrogen-rich water null human randomized controlled trial
• Hinhalation therapy in patients with moderate COVID-19 (HCOVID): a prospective ascending-dose phase I clinical trial.
  2024 ・ Antimicrob Agents Chemother ・ PMID 39016593
  inhalation positive human case report
• The Effect of 14-Day Consumption of Hydrogen-Rich Water Alleviates Fatigue but Does Not Ameliorate Dyspnea in Long-COVID Patients: A Pilot, Single-Blind, and Randomized, Controlled Trial.
  2024 ・ Nutrients ・ PMID 38794767
  hydrogen-rich water mixed human randomized controlled trial
• [Rehabilitation program of post-COVID-19 syndrome with the use of nitric oxide and molecular hydrogen].
  2024 ・ Ter Arkh ・ PMID 38713041
  inhalation positive human randomized controlled trial
• Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review.
  2024 ・ Int J Mol Sci ・ PMID 38256045
  hydrogen-rich water mixed meta-analysis
• The efficacy of hydrogen/oxygen therapy favored the recovery of omicron SARS-CoV-2 variant infection: results of a multicenter, randomized, controlled trial.
  2023 ・ J Clin Biochem Nutr ・ PMID 37970554
  inhalation positive human randomized controlled trial
• Hydrogen Therapy and Its Future Prospects for Ameliorating COVID-19: Clinical Applications, Efficacy, and Modality.
  2023 ・ Biomedicines ・ PMID 37509530
  mixed routes not assessed review
• Trend of research on the medical use of molecular hydrogen: a bibliometric analysis.
  2023 ・ Med Gas Res ・ PMID 37077121
  mixed routes not assessed review
• Post-COVID-19 fatigue: A systematic review.
  2022 ・ Front Psychiatry ・ PMID 36032234
  inhalation positive review
• Malproduction of endogenous hydrogen gas in COVID-19.
  2022 ・ Front Cell Infect Microbiol ・ PMID 35967841
  not specified not assessed review
• Is It a Challenge to Use Molecular Hydrogen for Extending Flower Vase Life?
  2022 ・ Plants (Basel) ・ PMID 35631701
  not specified not assessed review
• Molecular hydrogen is a potential protective agent in the management of acute lung injury.
  2022 ・ Mol Med ・ PMID 35240982
  mixed routes not assessed review
• Molecular Hydrogen Positively Affects Physical and Respiratory Function in Acute Post-COVID-19 Patients: A New Perspective in Rehabilitation.
  2022 ・ Int J Environ Res Public Health ・ PMID 35206179
  inhalation positive human randomized controlled trial
• Molecular hydrogen is a promising therapeutic agent for pulmonary disease.
  2022 ・ J Zhejiang Univ Sci B ・ PMID 35187885
  mixed routes not assessed review
• Molecular Hydrogen: A Promising Adjunctive Strategy for the Treatment of the COVID-19.
  2021 ・ Front Med (Lausanne) ・ PMID 34746162
  inhalation not assessed review
• Combating Oxidative Stress and Inflammation in COVID-19 by Molecular Hydrogen Therapy: Mechanisms and Perspectives.
  2021 ・ Oxid Med Cell Longev ・ PMID 34646423
  mixed routes not assessed review
• Potential Therapeutic Applications of Hydrogen in Chronic Inflammatory Diseases: Possible Inhibiting Role on Mitochondrial Stress.
  2021 ・ Int J Mol Sci ・ PMID 33806292
  not specified not assessed review
• Chemical and Biochemical Aspects of Molecular Hydrogen in Treating Kawasaki Disease and COVID-19.
  2021 ・ Chem Res Toxicol ・ PMID 33719401
  inhalation not assessed review
• Molecular hydrogen (H) as a potential treatment for acute and chronic fatigue.
  2021 ・ Arch Pharm (Weinheim) ・ PMID 33368699
  not specified not assessed review
• Direct Targets and Subsequent Pathways for Molecular Hydrogen to Exert Multiple Functions: Focusing on Interventions in Radical Reactions.
  2021 ・ Curr Pharm Des ・ PMID 32767925
  not specified not assessed review
• Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
  2020 ・ Front Pharmacol ・ PMID 33178011
  inhalation not assessed review
• COVID-19 and molecular hydrogen inhalation.
  2020 ・ Ther Adv Respir Dis ・ PMID 32865158
  inhalation not assessed letter